StonvexLoading…
StonvexStonvexStonvexCore line items from OBT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $134.98M | $127.23M | $117.77M | $84.22M |
Operating Income | $51.56M | $34.82M | $37.15M | $30.28M |
Net Income | $41.61M | $27.88M | $29.48M | $24.36M |
EPS (Diluted) | $3.33 | $2.47 | $2.62 | $4.33 |
Total Assets | $2.66B | $2.51B | $2.49B | $2.29B |
Total Liabilities | $2.38B | $2.32B | $2.32B | $2.15B |
Cash & Equivalents | $204.23M | $150.33M | $147.38M | $86.08M |
Free Cash Flow OCF − CapEx | $41.33M | $32.87M | $40.96M | $28.94M |
Shares Outstanding | 13.37M | 11.35M | 11.30M | 5.64M |